Literature DB >> 18769201

Contact lenses and allergy.

Michael A Lemp1.   

Abstract

PURPOSE OF REVIEW: Ocular allergic conditions and contact lens wear affect a large percentage of the population; the implications for interaction of allergy and changes induced by contact lens wear are significant. In addition, contact lenses are used in the treatment of severe forms of ocular allergic disease. RECENT
FINDINGS: The major themes of this review are the effects of contact lens wear on tear-film dynamics and structure, the effects of ocular allergy on tear dynamics and structure, the intersection of these two influences, management of contact lens wear in the allergic patient and the use of contact lenses to manage severe ocular allergic disease.
SUMMARY: The use of newer oral and topical antiallergic drugs in contact lens patients, changes in recommendation for use and wearing schedules and recommendations for the use of scleral lenses in severe allergic-based ocular surface disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769201     DOI: 10.1097/ACI.0b013e32830e6adc

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  4 in total

Review 1.  Artificial tears potpourri: a literature review.

Authors:  Majid Moshirfar; Kasey Pierson; Kamalani Hanamaikai; Luis Santiago-Caban; Valliammai Muthappan; Samuel F Passi
Journal:  Clin Ophthalmol       Date:  2014-07-31

2.  Demodex sp. as a Potential Cause of the Abandonment of Soft Contact Lenses by Their Existing Users.

Authors:  Witold Tarkowski; Joanna Moneta-Wielgoś; Daniel Młocicki
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

Review 3.  The role of lipids in corneal diseases and dystrophies: a systematic review.

Authors:  Tyler G Rowsey; Dimitrios Karamichos
Journal:  Clin Transl Med       Date:  2017-08-11

4.  Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study.

Authors:  Nir Erdinest; Haim Ovadia; Ran Kormas; Abraham Solomon
Journal:  J Inflamm (Lond)       Date:  2014-03-02       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.